Skip to main content

September 2017

 

 

academics

 

Clinical research courses

Applications are invited for the post of Senior research fellow at IITK

The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”. The Parliamentary Act has given absolute autonomy to the IITs. When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme)

Applications are invited for the post of Senior research fellow in the Department of Biotechnology (DBT) sponsored research Project.

Post: Senior Research Fellow (One)

Career as Scientist in Analytical Research Development at United States Pharmacopeia

The United States Pharmacopeia (USP) is a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other healthcare products manufactured or sold in the United States. USP also sets widely recognized standards for food ingredients and dietary supplements. USP sets standards for the quality, purity, strength, and consistency of these products–critical to the public health.

Sanofi looking for Executive in Quality Control

Sanofi - aventis, one of the world's leading pharmaceutical companies, is a team of 1,00,000 individuals driven by one common mission to improve people's health and quality of life. Present in more than 100 countries, we are vibrant, people centric, performance driven organization contributing to distinctive healthcare. We invite dynamic enthusiastic individuals to be a part of the team at our state- of- the - art Ankleshwar site, that has set the gold standard in terms of manufacturing plant and processes in the Indian pharmaceutical industry.

Post : Executive Quality Control

Abbott India Limited require Business Manager

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Business Manager

Work as Project manager at Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Project manager

MacroGenics, Inc a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases, today announced the advancement of two of its proprietary bispecific DART product candidates. This progress includes: a first patient has been dosed with MGD013, a DART molecule that recognizes PD-1 and LAG-3; and the submission of an Investigational New Drug (IND) application with the FDA for MGD014, a DART molecule that targets HIV-infected cells and CD3. MacroGenics retains worldwide rights to both of these product candidates.

Boehringer Ingelheim and Gubra announce a collaboration and license agreement for the development of novel peptide compounds to treat obesity. The collaboration will bring together Gubra’s expertise in the design, synthesis, characterization and in in vivo testing of therapeutic peptides with Boehringer Ingelheim’s expertise in the development of innovative medicines for patients with cardiometabolic disease. It further expands and complements Boehringer Ingelheim’s comprehensive research and development portfolio in cardiometabolic diseases, one of the company’s core focus areas.

ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the presentation of the full data from its Phase 2b study evaluating eryaspase (GRASPA®) in combination with chemotherapy for the treatment of metastatic pancreatic cancer. The open-label, multi-center, randomized Phase 2b clinical study met its co-primary endpoints and demonstrated significant improvement in both overall survival (OS) and progression-free survival (PFS). The results will be presented during the European Society for Medical Oncology (ESMO) Annual Meeting in Madrid.

Clinical Trial Supply Southern California 2017

Building on the success of the Clinical Trial Supply Conference last November, we are delighted to announce that the 7th annual event will return to San Diego on 29th - 30th of November 2017. Looking to 2018, with important regulatory changes inbound in the form of Annex 16 & Annex 6, the event will surely prove an ideal meeting place for the industry to discuss organisational changes which will be brought on by the changing industry landscape.

4th International Conference NIPiCON 2018 at Institute of Pharmacy, Nirma University

Nirma University, Ahmedabad has been established in the year 2003 as a statutory university under the Gujarat State Act by the initiative of the Nirma Education & Research Foundation (NERF). The University is recognized by the University Grants Commission (UGC) under section 2(f) of the UGC Act. The achievement of 'A' grade by NAAC by National Assessment and Accreditation Council (NAAC) in November, 2015 once again manifests that the University is committed to quality teaching-learning and research and is accomplishing the promise by making it the first private university of Gujarat to achieve such honour. Nirma University is a member of the Association of Indian Universities (AIU) and the Association of Commonwealth Universities (ACU). The University has SIRO (Scientific and Industrial Research Organization) recognition from DSIR, Department of Science and Technology, Government of India. Dr. Karsanbhai K. Patel, Chairman, Nirma Group of Companies and Chairman, NERF is the President of the University. Nirma University consists of Faculty of Engineering and Technology, Faculty of Management, Faculty of Pharmacy, Faculty of Science, Faculty of Doctoral Studies & Research, Faculty of Law, Faculty of Architecture and Planning, Faculty of Commerce and Department of Design. The graduate, post graduate and doctoral level programmes offered by these faculties are rated high by industry, business magazines and students. Innovation, excellence and quality are the driving forces on the campus and this has translated the vision of these institutions into a reality over a short period of time. The 125-acre sprawling green campus with serene picturesque landscape provides refreshing environment for intellectual and creative activities. Today the campus vibrates with not only world class curricular activities but also with myriad events like international conventions symposia, conferences, student competitions, conclaves, short-term industry relevant programs, cultural activities, etc.